Viral Vector Manufacturing Market Dynamics and Competitive Landscape Analysis
“The global viral vector manufacturing market size was valued at USD 696.17 million in 2023 and is projected to grow at a CAGR of 19.22% from 2024 to 2030, reaching USD 1,995.43 million by the end of the forecast period.” The viral vector manufacturing market has seen significant growth, driven by advancements in gene therapy, vaccines, and molecular biology research. Viral vectors, crucial for delivering genetic material into cells, play a pivotal role in these applications, leading to increased demand and expansion of the market. Viral Vector Manufacturing Market Analysis and Size The global viral vector manufacturing market has been expanding at a rapid pace. Additionally, viral vectors are regarded as an appealing and suitable option for cancer therapy due to their numerous benefits. These include high gene transduction efficiency, accurate gene delivery to target cells, robust immune response induction, and enhanced cellular immunity. These advantages are essential in addressing